Johnson & Johnson released results from a phase 3 study, showing that the combination of Rybrevant and Lazcluze significantly improved overall survival in patients with advanced non-small cell lung ...

The awards honor organizations that demonstrate exceptional performance in patient care and quality outcomes. This year, eight hospitals were recognized based on their achievements in 10 core quality ...